IMU Biosciences Funding: $166M Raised, Series A (2026)
IMU Biosciences is a Biotech company based in London, United Kingdom. It has raised $166M in total funding. Latest round: Series A.
IMU Biosciences funding overview
IMU Biosciences is a Biotech company based in London, United Kingdom. IMU Biosciences has raised $166M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2026. The round record for IMU Biosciences runs through 2026; nothing later has been disclosed. Investors on record include IQ Capital, Molten Ventures, British Business Bank, Meltwind, Kfund, LifeX Ventures. 6 distinct backers are named across the disclosed rounds.
IMU Biosciences at a glance
Total raised
$166M
Latest round
Series A
Latest round date
June 2026
Industry
Biotech
Headquarters
London, United Kingdom
Notable investors
IQ Capital, Molten Ventures, British Business Bank, Meltwind, Kfund, LifeX Ventures
Frequently asked about IMU Biosciences funding
How much has IMU Biosciences raised?
IMU Biosciences has raised $166M in total disclosed funding across the rounds on record.
Who has invested in IMU Biosciences?
IQ Capital, Molten Ventures, British Business Bank, Meltwind, Kfund, LifeX Ventures are named among the investors backing IMU Biosciences.
What was the latest IMU Biosciences funding round?
The most recent disclosed round is a Series A, announced in June 2026.
Where is IMU Biosciences based?
IMU Biosciences is based in London, United Kingdom.
What sector does IMU Biosciences operate in?
IMU Biosciences is tracked under Biotech from London, United Kingdom, with $166M in disclosed funding.
When did IMU Biosciences last raise?
The last disclosed IMU Biosciences round closed in June 2026 at Series A.
Totals shown for IMU Biosciences aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in London and the investors behind them below.
